Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

Table 1 Patient Characteristics

		N.A	Adjuvant	p
N P Stage IIIa		30	21
Age	Mean	59.83	60.10	0.939
Male	N	18	17	0.220
Male	%	51.43	48.57
FEV1(%)	Mean	69.39	72.88	0.644
Laterality of procedure
Right		13	14	0.154
Left		17	7	0.154
Histological type
Adenocarcinoma		35.5	28.6
Squamous cell carcinoma		48.4	28.6
Metastatic thymoma		6.5
Large cell carcinoma		9.6	9.5
Malignant mesothelioma			28.6
Bronchiolo-alveolar carcinoma			4.7

ISSN: 1749-8090